These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 2999214

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. [Symptomology of non-invasive proliferative epithelial changes in the breast].
    Geppert M, Bachmann FF.
    Med Welt; 1982 Jul 16; 33(28):1020-3. PubMed ID: 6289038
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Fine-needle aspiration cytology of lobular carcinoma in situ.
    Ustün M, Berner A, Davidson B, Risberg B.
    Diagn Cytopathol; 2002 Jul 16; 27(1):22-6. PubMed ID: 12112810
    [Abstract] [Full Text] [Related]

  • 46. Breast cancer: a review of the literature.
    Richie RC, Swanson JO.
    J Insur Med; 2003 Jul 16; 35(2):85-101. PubMed ID: 14733031
    [Abstract] [Full Text] [Related]

  • 47. Is core needle biopsy superior to fine-needle aspiration biopsy in the diagnosis of papillary breast lesions?
    Masood S, Loya A, Khalbuss W.
    Diagn Cytopathol; 2003 Jun 16; 28(6):329-34. PubMed ID: 12768640
    [Abstract] [Full Text] [Related]

  • 48. Interobserver reproducibility.
    Lobert PF.
    Am J Surg Pathol; 1993 Oct 16; 17(10):1071-2. PubMed ID: 8396857
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. [Minimal carcinoma of the breast: incidence on mass screening].
    Virno F.
    Minerva Chir; 1989 Feb 15; 44(3):399-400. PubMed ID: 2541373
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Increased detection of occult breast carcinoma after more thorough histologic examination of breast biopsies.
    Patchefsky AS, Potok J, Hoch WS, Libshitz HI.
    Am J Clin Pathol; 1973 Dec 15; 60(6):799-804. PubMed ID: 4357121
    [No Abstract] [Full Text] [Related]

  • 55. 17 beta-Hydroxysteroid dehydrogenase type 1 and type 2 in ductal carcinoma in situ and intraductal proliferative lesions of the human breast.
    Ariga N, Moriya T, Suzuki T, Kimura M, Ohuchi N, Satomi S, Sasano H.
    Anticancer Res; 2000 Dec 15; 20(2B):1101-8. PubMed ID: 10810403
    [Abstract] [Full Text] [Related]

  • 56. [Fibroadenoma of the breast with atypical clear-cell epithelial hyperplasia. Apropos of 7 cases. Immunohistochemical study].
    Lacombe MJ, Llombart-Bosch A, Lecluse Y, Bertin F, Contesso G.
    Ann Pathol; 1986 Dec 15; 6(1):37-44. PubMed ID: 3521628
    [Abstract] [Full Text] [Related]

  • 57. Cytological criteria for the diagnosis of intraductal hyperplasia, ductal carcinoma in situ, and invasive carcinoma of the breast.
    Bofin AM, Lydersen S, Hagmar BM.
    Diagn Cytopathol; 2004 Oct 15; 31(4):207-15. PubMed ID: 15452908
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.